Skip to main content
Menu
Return to Home
Home
Home
Assessing appropriateness of take-away dosing to support continuity of pharmacotherapy during COVID-19 pandemic
Assessing appropriateness of take-away dosing to support continuity of pharmacotherapy during COVID-19 pandemic
Details
Date published
16 Oct 2021
Downloads
Assessing appropriateness of take-away dosing to support continuity of pharmacotherapy during COVID-19 pandemic
pdf
180.21 KB
Reviewed 17 October 2021
Share this page
Twitter
, opens a new window
Facebook
, opens a new window
LinkedIn
, opens a new window
Was this page helpful?
Yes
No
Tell me your email for content rating
